Cerebral Protein Hydrolysate Injection. It is used to treat symptoms of primary dementia, vascular dementia, impairment of cognitive function after moderate to mild stroke, mixed dementia, and improvement of brain dysfunction due to craniocerebral injury.
Brain protein hydrolysate injection occasionally produces adverse reactions such as anxiety and insomnia, and individual patients may experience unstable blood pressure, fatigue, cough tremor, numbness, nausea and vomiting, constipation, limb pain, shortness of breath, and depression after taking the drug. Injecting too fast may lead to arrhythmia or red itchy skin.
Brain protein hydrolysate injection is prohibited for those who are allergic to any component of brain protein hydrolysate injection, patients with severe renal insufficiency is prohibited, epileptic patients should be used with caution, prohibit mixing and matching, and be careful with the combination of drugs. If you need to use Brain Protein Hydrolysate Injection, please consult a professional doctor, follow the doctor’s instructions, reasonable use of medication.